Reconciling neuronally and nonneuronally derived acetylcholine in the regulation of immune function

Annals of the New York Academy of Sciences

Volumn 1261, Issue 1, 2012, Pages 7-17

  Kawashima, Koichiro ^a,b   Fujii, Takeshi ^c   Moriwaki, Yasuhiro ^d   Misawa, Hidemi ^d   Horiguchi, Kazuhide ^e  

^a KITASATO UNIVERSITY   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

^c DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e UNIVERSITY OF FUKUI   (Japan)

Author keywords

Choline acetyltransferase; Cytokine; MAChR; NAChR; SLURP 1; T cell

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; ATROPINE; AUTOCRINE MOTILITY FACTOR; CHOLINE ACETYLTRANSFERASE; IMMUNOGLOBULIN G1; MESSENGER RNA; METHYLLYCACONITINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ACETYLCHOLINE RELEASE; ARTICLE; AUTOCRINE EFFECT; BLOOD ANALYSIS; CHOLINERGIC TRANSMISSION; CYTOKINE PRODUCTION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; NONHUMAN; PARACRINE SIGNALING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84864075885     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06516.x     Document Type: Article

References (80)

1. Ewins, A.J. 1914. Acetylcholine, a new active principle of ergot. Biochem. J. 8: 44-49.
2. Dale, H.H & H.W. Dudley. 1929. The presence of histamine and acetylcholine in the spleen of the ox and the horse. J. Physiol. (London) 68: 97-123.
3. Dale, H.H. 1935. Walter Ernest Dixon Memorial Lecture. Pharmacology and nerve-endings. Proc. R. Soc. Med. 28: 15-28.
4. Loewi, O. 1921. Über humorale Übertrgbarkeit der Herznwirkung. Pflügers Arch. Ges. Physiol. 189: 239-242.
5. Horiuchi, Y., R. Kimura, N. Kato, et al. 2003. Evolutional study on acetylcholine expression. Life Sci. 72: 1745-1756.
6. Yamada, T., T. Fujii, T. Kanai, et al. 2005. Expression of acetylcholine (ACh) and ACh-synthesizing activity in archaea. Life Sci. 77: 1935-1944.
7. Kawashima, K. & T. Fujii. 2000. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 86: 29-48.
8. Kawashima, K. & T. Fujii. 2003. Minireview: the lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 74: 675-696.
9. Kawashima, K. & T. Fujii. 2004. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 9: 2063-2085.
10. Kawashima, K. & T. Fujii. 2008. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J. Pharmacol. Sci. 106: 167-173.
11. Fujii, T., Y. Takada-Takatori & K. Kawashima. 2008. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J. Pharmacol. Sci. 106: 186-192.
12. Grando, S.A., K. Kawashima, C.J. Kirkpatrick & I. Wessler. 2007. Introduction: recent progress in understanding the non-neuronal cholinergic system in humans. Life Sci. 80: 2181-2185.
13. Wessler, I., C.J. Kirkpatrick & K. Racké. 1998. Non-neuronal acetylcholine, a locally acting molecule widely distributed in biological system: expression and function in humans. Pharmacol. Ther. 77: 59-79.
14. Tucek, S. 1982. The synthesis of acetylcholine in skeletal muscles of the rat. J. Physiol. (London) 322: 53-69.
15. Kawashima, K., K. Yoshikawa, Y.X. Fujii, et al. 2007. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci. 80: 2314-2319.
16. Borovikova, L.V., S. Ivanova, M. Zhang, et al. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462.
17. Pavlov, V.A., H. Wang, C.J. Czura, et al. 2003. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9: 125-134.
18. Huston, J.M., M. Ochani, M. Rosas-Ballina, et al. 2006. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203: 1623-1628.
19. Bellinger, D.L., D. Lorton, R.W. Hamill, et al. 1993. Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation. Brain Behav. Immun. 17: 191-204.
20. Berthoud, H.R. & T.L. Powley. 1996. Interaction between parasympathetic and sympathetic nerves in prevertebral ganglia: morphological evidence for vagal efferent innervation of ganglion cells in the rat. Microsc. Res. Tech. 35: 80-86.
21. Rosas-Ballina, M., P.S. Olofsson, M. Ochani, et al. 2011. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334: 98-101.
22. Fujii, T., S. Yamada, H. Misawa, et al. 1995. Expression of choline acetyltransferase mRNA and protein in T-lymphocytes. Proc. Japan Acad. 71B: 231-235.
23. Fujii, T., Y. Watanabe, K. Fujimoto & K. Kawashima. 2003. Expression of acetylcholine in lymphocytes and modulation of an independent lymphocytic cholinergic activity by immunological stimulation. Biog. Amine. 17: 373-386.
24. Kapfhammer, J. & C. Bischoff. 1930. Acetylcholin und Cholin aus tierischen Organen. Z. Physiol. Chem. 191: 179-182.
25. Kawashima, K., H. Oohata, T. Suzuki & K. Fujimoto. 1989. Extraneuronal localization of acetylcholine and its release upon nicotine stimulation. Neurosci. Lett. 104: 336-339.
26. Kawashima, K., K. Kajiyama, K. Fujimoto, et al. 1993. Presence of acetylcholine in human blood and its localization in circulating mononuclear leukocytes. Biog. Amine. 9: 251-258.
27. Fujii, T., S. Yamada, N. Yamaguchi, et al. 1995. Species differences in the acetylcholine content in blood and plasma. Neurosci. Lett. 201: 207-210.
28. Yamada, S., T. Fujii, K. Fujimoto, et al. 1997. Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs. Neurosci. Lett. 225: 25-28.
29. Fujii, T., Y. Mori, T. Tominaga, et al. 1997. Maintenance of constant blood acetylcholine content before and after feeding in young chimpanzees. Neurosci. Lett. 227: 21-24.
30. Kajiyama, K., T. Suzuki, K. Fujimoto & K. Kawashima. 1991. Determination of acetylcholine content and choline acetyltransferase activity in rabbit blood cells obtained from buffy coat layer. Japan J. Pharmacol. 55(Suppl. I): 194P.
31. Kajiyama, K., K. Fujimoto, T. Suzuki, et al. 1992. Localization of acetylcholine and choline acetyltransferase activity in human mononuclear leukocytes. Japan J. Pharmacol. 58(Suppl. I): 59P.
32. Rinner, I., K. Kawashima & K. Schauenstein. 1998. Rat lymphocytes produce and secrete acetylcholine in dependence of differentiation and activation. J. Neuroimmunol. 81: 31-37.
33. Hagforsen, E., A. Einarsson, F. Aronsson, et al. 2000. The distribution of choline acetyltransferase- and acetylcholinesterase-like immunoreactivity in the palmar skin of patients with palmoplantar pustulosis. Br. J. Dermatol. 142: 234-242.
34. Wessler, I. & C.J. Kirkpatrick. 2008. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol. 154: 1558-1571.
35. Kawashima, K., N. Watanabe, H. Oohata, et al. 1990. Synthesis and release of acetylcholine by cultured bovine arterial endothelial cells. Neurosci. Lett. 119: 156-158.
36. Ikeda, C., I. Morita, A. Mori, et al. 1994. Phorbol ester stimulates acetylcholine synthesis in cultured endothelial cells isolated from porcine cerebral microvessels. Brain Res. 655: 147-152.
37. Kirkpatrick, C.J., F. Bittinger, R.E. Unger, et al. 2001. The non-neuronal cholinergic system in the endothelium: evidence and possible pathological significance. Japan. J. Pharmacol. 85: 24-28.
38. Haberberger, R.V., M. Bodenbenner, & W. Kummer. 2000. Expression of the cholinergic gene locus in pulmonary arterial endothelial cells. Histochem. Cell Biol. 113: 379-387.
39. Fujii, T., Y. Takada-Takatori & K. Kawashima. 2012. Regulatory mechanisms of acetylcholine synthesis and release by T cells. Life Sci. In press.
40. Fujii, T., T. Tsuchiya, S. Yamada, et al. 1996. Localization and synthesis of acetylcholine in human leukemic T-cell lines. J. Neurosci. Res. 44: 66-72.
41. Fujii, T., S. Yamada, Y. Watanabe, et al. 1998. Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator. J. Neuroimmunol. 82: 101-107.
42. Suenaga, A., T. Fujii, T. Maruyama, et al. 2004. Up-regulation of lymphocytic cholinergic activity by ONO-4819, a specific prostaglandin EP4 receptor agonist, in MOLT-3 human leukemic T cells. Vasc. Pharmacol. 41: 51-58.
43. Fujii, T. & K. Kawashima. 2002. Effects of human antithymocyte globulin on acetylcholine synthesis, its release and choline acetyltransferase transcription in a human leukemic T-cell line. J. Neuroimmunol. 128: 1-8.
44. Fujii, T., K. Masuyama & K. Kawashima. 2006. Simvastatin regulates non-neuronal cholinergic activity in T lymphocytes via CD11a-mediated pathways. J. Neuroimmunol. 179: 101-107.
45. 5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses. Neurochem. Res. 28: 423-429.
46. Fujii, T., Y. Takada-Takatori, K. Horiguchi & K. Kawashima. 2012. Mediatophore regulates acetylcholine release from T cells. J. Neuroimmunol. 244: 16-22.
47. + antiport in rapid neurotransmission. Ann. N.Y. Acad. Sci. 1152: 100-112.
48. Bonner, T.I., N.J. Buckley, A.C Young & M.R. Brann. 1987. Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527-532.
49. Alexander, S.P.H. & J.A. Peters. 1999. Tips receptor and ion channel nomenclature (10th ed.). Trends Pharmacol. Sci. 20(Suppl.): 6-8.
50. Hulme, E.C., N.J.M. Birdsall & N.J. Buckley. 1990. Muscarinic receptor subtypes. Ann. Rev. Pharmacol. Toxicol. 30: 633-673.
51. Sato, K.Z., T. Fujii, Y. Watanabe, et al. 1999. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci. Lett. 266: 17-20.
52. Abe, K., T. Fujii, S. Iho, et al. 2004. Detection of α9 and α10 nicotinic acetylcholine receptor subunits in human T and B lymphocytes. J. Pharmacol. Sci. 94 (Suppl. I): 202P.
53. Qian, J., V. Galitovskiy, A.I. Chernyavsky, et al. 2011. Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun. 12: 222-230.
54. Fujii, T. & K. Kawashima. 2000. Calcium oscillation is induced by muscarinic acetylcholine receptor stimulation in human leukemic T- and B-cell lines. Naunyn-Schmiedberg's Arch. Pharmacol. 362: 14-21.
55. 3 muscarinic acetylcholine receptors in human T- and B-cells. Japan. J. Pharmacol. 84: 124-132.
56. Fujino, H., Y. Kitamura, T. Yada, et al. 1997. Stimulatory roles of muscarinic acetylcholine receptors in T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. Mol. Pharmacol. 51: 1007-1014.
57. Elgoyhen, A.B., D.E. Vetter, E. Katz, et al. 2001. α10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. USA. 98: 3501-3506.
58. 2+ signaling and down -regulation of nicotinic acetylcholine receptor subunit expression in the CEM human leukemic T-cell line. Life Sci. 72: 2155-2159.
59. + cytolytic T lymphocyte differentiation by a cholinergic pathway. J. Neuroimmunol. 164: 66-75.
60. + T cell-mediated anti-viral responses in mice with targeted deletions of the M1 or M5 muscarinic cholinergic receptors. Life Sci. 80: 2330-2333.
61. Sinha, K., K.D. Dannelly & S.K. Ghosh. 2001. Effects of T-lymphocyte-dependent and -independent immunity on cholinergic enzyme activity in mouse lacrimal gland. Exp. Physiol. 86: 169-176.
62. Fujii, T., Y. Watanabe, K. Fujimoto & K. Kawashima. 2005. Expression of acetylcholine in lymphocytes and modulation of an independent lymphocytic cholinergic activity by immunological stimulation. In Advances in Neuroregulation and Neuroprotection. C. Collin, M. Minami, H. Parves, H. Saito, G.A. Qureshi & C. Reiss, Eds.: 737-750. VSP. Leiden and Boston.
63. 5 muscarinic acetylcholine receptor knockout mice. J. Neuroimmunol. 188: 80-85.
64. + T cells is required for optimal Th2 immunity to parasitic nematode infection. In The 3rd International Symposium on Non-Neuronal Acetylcholine, August 24-26, 2011. Groningen, The Netherlands. Abstract book 32P.
65. Wang, H., M. Yu, M. Ochani, et al. 2003. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
66. 1 and proinflammatory cytokine production in nicotinic acetylcholine receptor α7 subunit gene knockout mice. J. Neuroimmunol. 189: 69-74.
67. Skok, M.V., R. Grailhe, F. Agenes & J.P. Changeux. 2007. The roles of nicotinic receptors in B-lymphocyte development and activation. Life Sci. 80: 2334-2336.
68. Adermann, K., F. Wattler, S. Wattler, et al. 1999. Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Protein Sci. 8: 810-819.
69. Chimienti, F., R.C. Hogg, L. Plantard, et al. 2003. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum. Mol. Genet. 12: 3017-3024.
70. Arredondo, J., A.I. Chernyauski, D.L. Jolkowky, et al. 2005. Biological effects of SLURP-1 on human keratinocyte. J. Invest. Dermatol. 125: 1326-1341.
71. Fischer, J., B. Bouadjar, R. Heilig, et al. 2001. Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum. Mol. Genet. 10: 875-880.
72. Moriwaki, Y., K. Yoshikawa, H. Fukuda, et al. 2007. Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands. Life Sci. 80: 2365-2368.
73. Mastrangeli, R., S. Donini, C.A. Kelton, et al. 2003. ARS component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda. Eur. J. Dermatol. 13: 560-570.
74. Pettersson, A., S. Nordlander, G. Nylund, et al. 2008. Expression of the endogenous, nicotinic acetylcholine receptor ligand, SLURP-1, in human colon cancer. Auton. Autacoid Pharmacol. 28: 109-116.
75. Horiguchi, K., N. Yamashita, S. Horiguchi, et al. 2009. Expression of SLURP-1, an endogenous α7 nicotinic acetylcholine receptor allosteric ligand, in murine bronchial epithelial cells. J. Neurosci. Res. 87: 2740-2747.
76. Tjiu, J-W., P-J. Lin, W-H. Wu, et al. 2011. SLURP-1 mutation-impaired T-cell activation in a family with mal de Meleda. Br. J. Dermatol. 164: 47-53.
77. Gamse, R., P. Holzer & F. Lembeck. 1980. Decrease of substance P in primary afferent neurons and impairment of neurogenic plasma extravasation by capsaicin. Br. J. Pharmacol. 68: 207-213.
78. Li, Y., Y.C. Jiang & C. Owyang. 1998. Central CGRP inhibits pancreatic enzyme secretion by modulation of vagal parasympathetic outflow. Am. J. Physiol. 275: G957-G963.
79. Moriwaki, Y., Y. Watanabe, T. Shinagawa, et al. 2009. Primary sensory neuronal expression of SLURP-1, an endogenous nicotinic acetylcholine receptor ligand. Neurosci. Res. 64: 403-412.
80. Favre, B., L. Plantard, L. Aeschbach, et al. 2007. SLURP-1 is a late marker of epidermal differentiation and is absent in Mal de Meleda. J. Invest. Dermatol. 127: 301-308.